HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED EPITHELIAL OVARIAN-CANCER RESISTANT TO 1ST-LINE OR 2ND-LINE CHEMOTHERAPY

被引：37
作者：
MANGIONI, C
FRANCESCHI, S
LAVECCHIA, C
DINCALCI, M
机构：
[1] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY
[2] UNIV MILAN,OSTETRICA & GINECOL CLIN 1,I-20133 MILAN,ITALY
来源：
GYNECOLOGIC ONCOLOGY | 1981年 / 12卷 / 03期
关键词：
D O I：
10.1016/0090-8258(81)90131-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：314 / 318
页数：5
相关论文
共 7 条
[1]   TREATMENT OF ADVANCED CYSTADENOCARCINOMA OF THE OVARY WITH GESTRONOL AND CONTINUOUS ORAL CYCLOPHOSPHAMIDE [J].
GUTHRIE, D .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1979, 86 (07) :497-500
[2]  
HOLT JA, 1979, OBSTET GYNECOL, V53, P50
[3]   PROGESTERONE IN THE TREATMENT OF ADVANCED MALIGNANT TUMOURS OF BREAST, OVARY AND UTERUS [J].
JOLLES, B .
BRITISH JOURNAL OF CANCER, 1962, 16 (02) :209-221
[4]  
MALKASIAN GD, 1973, CANCER CHEMOTH REP 1, V57, P241
[5]  
MALKASIAN GD, 1977, CANCER TREAT REP, V61, P913
[6]  
VARGA A, 1964, OBSTET GYNECOL, V23, P51
[7]  
WARD HWC, 1972, J OBSTET GYN BR COMM, V79, P555
1